Prophylactic Administration of Bacterially Derived Immunomodulators Improves the Outcome of Influenza Virus Infection in a Murine Model
- 15 March 2010
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 84 (6), 2983-2995
- https://doi.org/10.1128/jvi.01805-09
Abstract
Prophylactic or therapeutic immunomodulation is an antigen-independent strategy that induces nonspecific immune system activation, thereby enhancing host defense to disease. In this study, we investigated the effect of prophylactic immunomodulation on the outcome of influenza virus infection using three bacterially derived immune-enhancing agents known for promoting distinct immunological profiles. BALB/c mice were treated nasally with either cholera toxin (CT), a mutant form of the CT-relatedEscherichia coliheat-labile enterotoxin designated LT(R192G), or CpG oligodeoxynucleotide. Mice were subsequently challenged with a lethal dose of influenza A/PR/8/34 virus 24 h after the last immunomodulation treatment and either monitored for survival or sacrificed postchallenge for viral and immunological analysis. Treatment with the three immunomodulators prevented or delayed mortality and weight loss, but only CT and LT(R192G) significantly reduced initial lung viral loads as measured by plaque assay. Analysis performed 4 days postinfection indicated that prophylactic treatments with CT, LT(R192G), or CpG resulted in significantly increased numbers of CD4 T cells, B cells, and dendritic cells and altered costimulatory marker expression in the airways of infected mice, coinciding with reduced expression of pulmonary chemokines and the appearance of inducible bronchus-associated lymphoid tissue-like structures in the lungs. Collectively, these results suggest that, despite different immunomodulatory mechanisms, CT, LT(R192G), and CpG induce an initial inflammatory process and enhance the immune response to primary influenza virus challenge while preventing potentially damaging chemokine expression. These studies provide insight into the immunological parameters and immune modulation strategies that have the potential to enhance the nonspecific host response to influenza virus infection.Keywords
This publication has 83 references indexed in Scilit:
- The role of neutrophils in the upper and lower respiratory tract during influenza virus infection of miceRespiratory Research, 2008
- Clearance of influenza virus from the lung depends on migratory langerin+CD11b− but not plasmacytoid dendritic cellsThe Journal of Experimental Medicine, 2008
- Local Not Systemic Modulation of Dendritic Cell S1P Receptors in Lung Blunts Virus-Specific Immune Responses to InfluenzaMolecular Pharmacology, 2008
- Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A/H5N1 virusProceedings of the National Academy of Sciences of the United States of America, 2008
- Induction of Heterosubtypic Immunity to Influenza Virus by Intranasal ImmunizationJournal of Virology, 2008
- Virally Delivered Cytokines Alter the Immune Response to Future Lung InfectionsJournal of Virology, 2007
- Roles of adjuvant and route of vaccination in antibody response and protection engendered by a synthetic matrix protein 2-based influenza A virus vaccine in the mouseVirology Journal, 2007
- Effect of adjuvants and route of immunizations on the immune response to recombinant plague antigensVaccine, 2007
- Evaluation of combinatorial vaccines against anthrax and plague in a murine modelVaccine, 2007
- CpG Oligodeoxynucleotide Treatment Enhances Innate Resistance and Acquired Immunity to African TrypanosomesInfection and Immunity, 2007